Effects of androgen supplementation of hormone replacement therapy on the vascular reactivity of cerebral arteries

Citation
M. Penotti et al., Effects of androgen supplementation of hormone replacement therapy on the vascular reactivity of cerebral arteries, FERT STERIL, 76(2), 2001, pp. 235-240
Citations number
23
Categorie Soggetti
Reproductive Medicine","da verificare
Journal title
FERTILITY AND STERILITY
ISSN journal
00150282 → ACNP
Volume
76
Issue
2
Year of publication
2001
Pages
235 - 240
Database
ISI
SICI code
0015-0282(200108)76:2<235:EOASOH>2.0.ZU;2-P
Abstract
Objective: To determine the effect of the androgen supplementation of hormo ne replacement therapy (HRT) on the vascular reactivity of cerebral arterie s. Design: Open randomized study. Setting: Healthy volunteers in an academic research environment. Patient(s): Forty postmenopausal women who were treated with sequential HRT (transdermal E-2 50 mug/d + medroxyprogesterone acetate 10 mg/d for 12 day s every other month) for greater than or equal to1 year and less than or eq ual to5 years. Intervention(s): Testosterone undecanoate (40 mg/d, p.o.) was randomly admi nistered to 20 patients during ongoing HRT; the other 20 served as controls . Doppler evaluations of the internal carotid and middle cerebral arteries were performed together with lipid levels assessments. A visual analogue sc ale (VAS) was used to evaluate various parameters relating to sexual life a nd well-being. Main Outcome Measure(s): Pulsatility index (PI) of the arteries, VAS assess ment of psychophysical well-being. Result(s): The administration of testosterone undecanoate during HRT induce d an increase in the PI of the middle cerebral artery and a reduction of hi gh-density lipoprotein cholesterol. Sexual desire and satisfaction were gre atly improved. Conclusion(s): In postmenopausal women, androgen supplementation during HRT can partially counteract the beneficial effects of estrogens on cerebral v ascular reactivity and lipid profiles, but sexual desire and satisfaction a re greatly improved. (C) 2001 by American Society for Reproductive Medicine .